Abstract:A CRISPR/Cas system represents an innovative tool for developing a new-generation biosensing and diagnostic strategy. However, the off-target issue (i.e., mistaken cleavage of nucleic acid targets and reporters) remains a great challenge for its practical applications. We hypothesize that this issue can be overcome by taking advantage of the site-specific cleavage ability of RNA-cleaving DNAzymes. To test this idea, we propose a DNAzyme Operation Enhances the Specificity of CRISPR/Cas13a strategy (termed DOES-CRISPR) to overcome the problem of relatively poor specificity that is typical of the traditional CRISPR/Cas13a system. The key to the design is that the partial hybridization of the CRISPR RNA (crRNA) with the cleavage fragment of off-target RNA was not able to activate the collateral cleavage activity of Cas13a. We showed that DOES-CRISPR can significantly improve the specificity of traditional CRISPR/Cas13a-based molecular detection by up to ∼43-fold. The broad utility of the strategy is illustrated through engineering three different systems for the detection of microRNAs (miR-17 and let-7e), CYP2C19*17 gene, SARS-Cov-2 variants (Gamma, Delta, and Omicron) and Omicron subtypes (BQ.1 and XBB.1) with single-nucleotide resolved specificity. Finally, clinical evaluation of this assay using 10 patient blood samples demonstrated a clinical sensitivity of 100% and specificity of 100% for genotyping CYP2C19*17, and analyzing 20 throat swab samples provided a diagnostic sensitivity of 95% and specificity of 100% for Omicron detection, and a clinical sensitivity of 92% and specificity of 100% for XBB.1 detection.

Massively parallel profiling of RNA-targeting CRISPR-Cas13d

Massively Parallel Biophysical Analysis of CRISPR-Cas Complexes on Next Generation Sequencing Chips.

Molecular mechanism for target RNA recognition and cleavage of Cas13h

Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage

Harnessing noncanonical trans -cleavage characteristics of Cas12 and Cas13a to enhance CRISPR-based diagnostics

Sensitive Analysis of Single Nucleotide Variation by Cas13d Orthologs, EsCas13d and RspCas13d

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Massively parallel Cas13 screens reveal principles for guide RNA design

A High-Fidelity DNAzyme-assisted CRISPR/Cas13a System with Single-Nucleotide Resolved Specificity

High-Fidelity DNAzyme-Assisted CRISPR/Cas13a System with Single-Nucleotide Resolved Specificity

Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Progress of CRISPR-based programmable RNA manipulation and detection.

Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage

A Sensitive Technique Unravels the Kinetics of Activation and Trans‐Cleavage of CRISPR‐Cas Systems

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

Efficient combinatorial targeting of RNA transcripts in single cells with Cas13 RNA Perturb-seq

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11

Advances in CRISPR-Cas systems for RNA targeting, tracking and editing